SNY CHMP opinion: Thursday, September 17, 2026

Variation type II · LEMTRADA · A grouped application consisting of: C.4: Update of section 4.4 of the SmPC in order to add a new warning on vasculitis based on data from clinical studies and post-authorisation data sources. The RMP version 14.0 has also been submitted. In addition, the MAH took the

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.